5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma

Elias Assaf,Muriel Verlinde-Carvalho,C. Delbaldo,Julien Grenier,Zineb Sellam,Damien Pouessel,Linda Bouaita,Isabelle Baumgaertner,Iradj Sobhani,Claude Tayar,Muriel Paul,Stéphane Culine

5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma

2011

Elias Assaf
Muriel Verlinde-Carvalho
C. Delbaldo
Julien Grenier
Zineb Sellam
Damien Pouessel
Linda Bouaita
Isabelle Baumgaertner
Iradj Sobhani
Claude Tayar
Muriel Paul
Stéphane Culine

Background: To evaluate the efficacy and toxicity of irinotecan and oxaliplatin plus 5-fluorouracil (FU) and leucovorin (FOLFIRINOX) as second-line therapy in metastatic pancreatic

Keywords:

Oncology
Pathology
Pancreatic disease
Thymidylate synthase
Fluorouracil
Oxaliplatin
Metastatic Pancreatic Adenocarcinoma
Medicine
Irinotecan
FOLFIRINOX
Surgery
Chemotherapy
Internal medicine
Antimetabolite

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations